AGL
agilon health, inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+19/100
Last price
83.40
▼ 0.88 (1.04%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
85.14
Prev close
84.28
Day high
86.26
Day low
83.01
Volume
168.53K
Market cap
$1.40B
P/E (TTM)
—
52W range
7.48 – 133.04
Day trading desk
Gap from prior close
+1.02%
Prior close 84.28
VWAP
84.30
-1.07% from price
Relative volume
1.33×
Normal
Session range
3.94%
82.99 – 86.26
Position in range
13%
Near session low
ATR (14D)
5.25
6.29% of price
Prior day high
85.82
PDH
Prior day low
82.60
PDL
Bid / ask spread
—
Quote not published
Session volume
390.54K
Avg 294.34K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+6.72%
+4.8%
1M
-5.76%
-6.9%
3M
-25.40%
-29.9%
6M
+402.71%
+384.5%
YTD
+384.18%
+369.9%
1Y
+195.22%
+178.8%
3Y
-81.22%
-163.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AGL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
846.95K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 2, 26 | WILLIAMS RONALD A Director |
STOCK | 2.13K | $0 | Direct |
| Jun 2, 26 | MANSUKANI SHARAD S. Director |
STOCK | 2.13K | $0 | Direct |
| Jun 2, 26 | MCLOUGHLIN KAREN Director |
STOCK | 2.13K | $0 | Direct |
| Jun 2, 26 | MCKENZIE DIANA L Director |
STOCK | 2.13K | $0 | Direct |
| Jun 2, 26 | BATTAGLIA SILVANA Director |
STOCK | 2.13K | $0 | Direct |
| Jun 2, 26 | WULF JOHN WILLIAM Director |
STOCK | 2.13K | $0 | Direct |
| May 7, 26 | O'ROURKE TIMOTHY PATRICK Chief Executive Officer |
STOCK | 320.00K | $0 | Direct |
| Apr 1, 26 | SCHWANEKE JEFFREY A Chief Financial Officer |
STOCK | 75.00K | $0 | Direct |
| Apr 1, 26 | SHAKER BENJAMIN Officer |
STOCK | 70.00K | $0 | Direct |
| Apr 1, 26 | VENKATACHALIAH GIRISH Chief Technology Officer |
STOCK | 28.00K | $0 | Direct |
| Apr 1, 26 | GERTSCH TIMOTHY Officer |
STOCK | 10.00K | $0 | Direct |
| Apr 1, 26 | ZAMORE DENISE Officer |
STOCK | 50.00K | $0 | Direct |
| Mar 9, 26 | SHAKER BENJAMIN Officer |
— | 18.45K | — | Direct |
| Mar 9, 26 | VENKATACHALIAH GIRISH Chief Technology Officer |
— | 18.45K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
GERTSCH TIMOTHY |
Officer | 14.32K | Stock Award(Grant) |
MANSUKANI SHARAD S. |
Director | 56.24K | Stock Award(Grant) |
O'ROURKE TIMOTHY PATRICK |
Chief Executive Officer | 320.00K | Stock Award(Grant) |
SCHWANEKE JEFFREY A |
Chief Financial Officer | 141.23K | Stock Award(Grant) |
SELL STEVEN J |
Chief Executive Officer | 974.37K | Stock Award(Grant) |
SHAKER BENJAMIN |
Officer | 123.53K | Stock Award(Grant) |
VENKATACHALIAH GIRISH |
Chief Technology Officer | 38.66K | Stock Award(Grant) |
WILLIAMS RONALD A |
Director | 149.14K | Stock Award(Grant) |
WULF JOHN WILLIAM |
Director | 16.77K | Stock Award(Grant) |
ZAMORE DENISE |
Officer | 66.84K | Stock Award(Grant) |
Fundamentals
Market cap$1.40B
Enterprise value$1.25B
Revenue (TTM)$5.92B
Gross profit$13.84M
EBITDA$-239.72M
Net income$-251.22M
EPS (TTM)$-15.41
Free cash flow$-145.68M
Total cash$185.63M
Total debt$33.45M
Book value / share$13.56
Shares outstanding16.79M
Float10.93M
Short % of float9.98%
Dividend yield0.00%
Beta (5Y)3.00
Valuation & profitability ratios
Trailing P/E—
Forward P/E35.32
PEG ratio—
Price / sales—
Price / book6.15
EV / revenue0.21
EV / EBITDA-5.21
Gross margin0.23%
Operating margin1.30%
Profit margin-3.92%
Return on equity-78.94%
Return on assets-9.61%
Debt / equity14.70
Current ratio1.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.93B | $6.06B | $4.32B | $2.39B | -2.1% |
| Operating revenue | $5.92B | $6.05B | $4.31B | $2.38B | -2.1% |
| Cost of revenue | $6.09B | $6.06B | $4.25B | $2.28B | +0.6% |
| Gross profit | -$160.02M | $4.84M | $69.67M | $111.36M | -3,405.5% |
| Selling, general & admin | $238.54M | $268.91M | $285.76M | $207.79M | -11.3% |
| Total operating expense | $267.13M | $293.38M | $301.80M | $216.74M | -8.9% |
| Operating income | -$427.15M | -$288.53M | -$232.13M | -$105.38M | -48.0% |
| Net interest income | -$6.64M | -$6.18M | -$6.66M | -$4.48M | -7.5% |
| Pre-tax income | -$404.10M | -$248.83M | -$194.46M | -$90.67M | -62.4% |
| Tax provision | $1.25M | $1.45M | $791.00K | $1.64M | -13.8% |
| Net income | -$391.35M | -$260.15M | -$262.60M | -$106.55M | -50.4% |
| Net income to common | -$391.35M | -$260.15M | -$262.60M | -$106.55M | -50.4% |
| Basic EPS | -23.75 | -15.75 | -16.00 | -6.50 | -50.8% |
| Diluted EPS | -23.75 | -15.75 | -16.00 | -6.50 | -50.8% |
| EBIT | -$397.45M | -$242.65M | -$187.80M | -$86.19M | -63.8% |
| EBITDA | -$368.86M | -$218.19M | -$167.64M | -$72.41M | -69.1% |
| Basic shares | 16.56M | 16.44M | 16.36M | 16.33M | +0.7% |
| Diluted shares | 16.56M | 16.44M | 16.36M | 16.33M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $173.71M | $188.23M | $107.57M | $465.30M | — | -7.7% |
| Cash & short-term investments | $285.14M | $399.97M | $488.34M | $877.20M | — | -28.7% |
| Accounts receivable | $673.79M | $1.02B | $942.46M | $492.36M | — | -33.7% |
| Total current assets | $1.10B | $1.46B | $1.48B | $1.45B | — | -24.8% |
| Property, plant & equipment | $28.96M | $36.95M | $40.99M | $31.95M | — | -21.6% |
| Goodwill & intangibles | $65.72M | $96.90M | $87.90M | $20.96M | — | -32.2% |
| Total assets | $1.27B | $1.73B | $1.74B | $1.70B | — | -26.7% |
| Total current liabilities | $1.08B | $1.15B | $977.16M | $535.09M | — | -6.6% |
| Current debt | $19.24M | — | $6.25M | $5.00M | $5.00M | — |
| Long-term debt | $15.75M | $34.90M | $32.31M | $38.48M | — | -54.9% |
| Total debt | $36.81M | $41.50M | $43.21M | $52.57M | — | -11.3% |
| Total liabilities | $1.14B | $1.26B | $1.08B | $656.86M | — | -9.4% |
| Retained earnings | -$1.98B | -$1.59B | -$1.33B | -$1.06B | — | -24.7% |
| Shareholder equity | $126.73M | $470.95M | $661.84M | $1.04B | — | -73.1% |
| Working capital | $20.21M | $305.77M | $502.92M | $916.18M | — | -93.4% |
| Net tangible assets | $61.01M | $374.05M | $573.94M | $1.02B | — | -83.7% |
| Shares issued | 16.59M | 16.49M | 16.26M | 16.50M | — | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$391.35M | -$260.10M | -$262.80M | -$106.86M | -50.5% |
| Depreciation & amortisation | $28.59M | $24.46M | $20.16M | $13.77M | +16.9% |
| Stock-based compensation | $49.12M | $50.66M | $69.50M | $28.38M | -3.0% |
| Change in working capital | $189.47M | $130.59M | -$10.07M | -$59.44M | +45.1% |
| Operating cash flow | -$105.76M | -$57.78M | -$156.20M | -$130.81M | -83.1% |
| Capital expenditure | -$43.11M | -$41.28M | -$30.82M | -$32.66M | -4.4% |
| Investing cash flow | $88.61M | $139.89M | -$44.02M | -$444.39M | -36.7% |
| Share buybacks | -$2.99M | $0 | -$200.00M | $0 | — |
| Financing cash flow | -$2.99M | -$2.58M | -$193.13M | $28.06M | -15.9% |
| Free cash flow | -$148.87M | -$99.06M | -$187.01M | -$163.47M | -50.3% |
| End cash position | $173.71M | $193.86M | $114.33M | $507.68M | -10.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.49B | $1.42B | $1.57B | $1.44B | $1.39B | +5.2% |
| Operating revenue | $1.49B | $1.42B | $1.57B | $1.43B | $1.39B | +5.2% |
| Cost of revenue | $1.39B | $1.36B | $1.66B | $1.50B | $1.45B | +2.4% |
| Gross profit | $107.14M | $65.02M | -$90.67M | -$67.65M | -$52.43M | +64.8% |
| Selling, general & admin | $88.50M | $54.23M | $60.10M | $56.20M | $56.28M | +63.2% |
| Total operating expense | $95.37M | $61.02M | $67.07M | $63.63M | $63.60M | +56.3% |
| Operating income | $11.77M | $4.00M | -$157.74M | -$131.27M | -$116.03M | +194.5% |
| Net interest income | -$1.61M | -$1.81M | -$1.72M | -$1.84M | -$1.57M | +11.2% |
| Pre-tax income | $17.58M | $29.94M | -$187.56M | -$110.54M | -$104.31M | -41.3% |
| Tax provision | -$375.00K | $28.00K | $1.32M | -$331.00K | $62.00K | -1,439.3% |
| Net income | $17.96M | $48.92M | -$188.88M | -$110.21M | -$104.37M | -63.3% |
| Net income to common | $17.96M | $48.92M | -$188.88M | -$110.21M | -$104.37M | -63.3% |
| Basic EPS | 1.07 | 2.95 | -11.50 | -6.75 | -6.31 | -63.7% |
| Diluted EPS | 1.04 | 2.94 | -11.50 | -6.75 | -6.31 | -64.6% |
| EBIT | $19.19M | $31.75M | -$185.84M | -$108.70M | -$102.74M | -39.6% |
| EBITDA | $26.05M | $38.54M | -$178.87M | -$101.27M | -$95.42M | -32.4% |
| Basic shares | 16.70M | 16.60M | 16.58M | 16.58M | 16.55M | +0.6% |
| Diluted shares | 17.21M | 16.66M | 16.58M | 16.58M | 16.55M | +3.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $107.18M | $139.99M | $173.71M | $171.68M | $171.42M | -23.4% |
| Cash & short-term investments | $185.63M | $231.41M | $285.14M | $310.85M | $327.00M | -19.8% |
| Accounts receivable | $1.06B | $899.75M | $673.79M | $947.16M | $1.05B | +17.8% |
| Total current assets | $1.42B | $1.32B | $1.10B | $1.34B | $1.45B | +7.4% |
| Property, plant & equipment | $29.39M | $30.13M | $28.96M | $30.08M | $36.24M | -2.4% |
| Goodwill & intangibles | $60.13M | $62.45M | $65.72M | $99.39M | $89.73M | -3.7% |
| Total assets | $1.59B | $1.50B | $1.27B | $1.60B | $1.71B | +5.7% |
| Total current liabilities | $1.31B | $1.27B | $1.08B | $1.24B | $1.25B | +3.1% |
| Current debt | $14.91M | $14.75M | $19.24M | $34.97M | $34.95M | +1.1% |
| Long-term debt | $15.38M | $15.28M | $15.75M | — | — | +0.6% |
| Total debt | $33.45M | $33.40M | $36.81M | $37.12M | $41.37M | +0.1% |
| Total liabilities | $1.36B | $1.32B | $1.14B | $1.29B | $1.30B | +3.0% |
| Retained earnings | -$1.91B | -$1.93B | -$1.98B | -$1.79B | -$1.68B | +0.9% |
| Shareholder equity | $227.53M | $181.43M | $126.73M | $306.08M | $408.93M | +25.4% |
| Working capital | $106.19M | $48.85M | $20.21M | $98.15M | $203.57M | +117.4% |
| Net tangible assets | $167.40M | $118.99M | $61.01M | $206.69M | $319.20M | +40.7% |
| Shares issued | 16.79M | 16.61M | 16.59M | 16.58M | 16.57M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $17.96M | $48.92M | -$188.88M | -$110.21M | -$104.37M | — | -63.3% |
| Depreciation & amortisation | $6.86M | $6.79M | $6.97M | $7.43M | $7.32M | — | +1.1% |
| Stock-based compensation | $23.83M | $6.25M | $9.52M | $7.50M | $15.38M | — | +281.0% |
| Change in working capital | -$113.99M | -$8.43M | $82.67M | $92.72M | $52.88M | — | -1,252.5% |
| Operating cash flow | -$57.30M | $23.73M | -$20.54M | -$18.15M | -$35.09M | — | -341.5% |
| Capital expenditure | -$4.31M | -$3.13M | -$9.76M | -$16.53M | -$5.93M | — | -37.8% |
| Investing cash flow | $19.91M | $19.27M | $22.58M | $18.66M | $70.46M | — | +3.3% |
| Share buybacks | — | -$35.00K | — | — | -$2.58M | -$161.00K | — |
| Financing cash flow | $4.63M | -$5.15M | -$17.00K | -$236.00K | -$2.58M | — | +190.0% |
| Free cash flow | -$61.60M | $20.60M | -$30.30M | -$34.69M | -$41.02M | — | -399.0% |
| End cash position | $178.81M | $211.57M | $173.71M | $171.68M | $171.42M | — | -15.5% |
Options analytics
Put / call volume
0.58
Call-heavy session
Put / call open interest
0.99
Positioning, not flow
Max pain
95.00
+13.9% from spot
ATM implied vol
75.6%
Nearest strike to spot
Skew (10% OTM)
+7.5%
Puts bid over calls
Call volume
185
Contracts, this expiry
Put volume
108
Contracts, this expiry
Heaviest call OI
85.00
193 contracts
Heaviest put OI
95.00
295 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.27 | 2.15 | +691.5% |
| Mar 2026 | 0.93 | 2.32 | +150.0% |
| Dec 2025 | -6.85 | -8.95 | -30.7% |
| Sep 2025 | -3.36 | -6.40 | -90.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.73 | 6 | $1.46B | +1.8% |
| Next quarter | -3.71 | 11 | $1.46B | -7.2% |
| Current year | -1.79 | 11 | $5.83B | -1.8% |
| Next year | 2.36 | 7 | $6.24B | +7.1% |
Analyst targets & ownership
Mean target$115.83
High target$146.00
Low target$85.00
Implied upside38.89%
Analyst count12
ConsensusBUY
Strong buy / Buy0 / 5
Hold9
Sell / Strong sell0 / 1
Held by insiders5.04%
Held by institutions96.57%
Institutions holding243
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
81.25
+2.65% from price
SMA 20
85.79
-2.79% from price
SMA 50
90.14
-7.48% from price
SMA 100
97.16
-14.16% from price
SMA 200
58.86
+41.68% from price
EMA 12
83.41
-0.01% from price
EMA 26
86.22
-3.27% from price
EMA 50
89.08
-6.38% from price
RSI (14)
44.7
Neutral
MACD (12,26,9)
-2.81
Hist 0.33
ATR (14)
5.25
6.29% of price
Realised vol 30D
48.3%
Annualised
Bollinger upper
96.14
20, 2σ
Bollinger lower
75.44
20, 2σ
50 / 200 cross
Golden
90.14 vs 58.86
Trend bias
Above 200
+41.68%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.45
More volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
48.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-71.8%
Peak to trough
Max drawdown 5Y
-98.9%
Peak to trough
ATR 14
5.25
6.29% of price
Beta (reported)
3.00
5Y monthly, from filing
Short interest
Shares short
1.05M
Prior 978.83K
Change vs prior
+7.3%
Shorts adding
% of float
9.98%
Normal
% of shares out
6.26%
Against total outstanding
Days to cover
5.2
Crowded exit
Float
10.93M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 26 | Bernstein | UPGRADE | Market Perform | Outperform |
| Aug 24, 26 | JP Morgan | MAINTAINED | Underweight | Underweight |
| Aug 11, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 11, 26 | Citigroup | UPGRADE | Sell | Neutral |
| Aug 6, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 6, 26 | Benchmark | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Aug 6, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 23, 26 | Citigroup | DOWNGRADE | Neutral | Sell |
| Jul 13, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| May 26, 26 | Barclays | UPGRADE | Underweight | Equal-Weight |
| May 21, 26 | Benchmark | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split1:25
Split dateMar 31, 2026
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-22
Corporate Changes & Voting Matters
8-K · 2026-06-03
Periodic Financial Reports
10-Q · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-04-27
Annual Report to Shareholders
ARS · 2026-04-23
Proxy Statements
DEF 14A · 2026-04-22
Corporate Changes & Voting Matters
8-K · 2026-03-30
Headlines
agilon health Sets Date to Report Third Quarter 2026 Financial Results
Business Wire · 1d ago
1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds
StockStory · 6d ago
Agilon Health Adds Jackson Clinic to Senior Health Connect ACO
MT Newswires · 6d ago
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Business Wire · 7d ago
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
Business Wire · 14d ago
How Investors Are Reacting To agilon health (AGL) Expanding Full-Risk Medicare Partnership With Family Practice Center
Simply Wall St. · 20d ago
agilon health (AGL) On Bernstein Upgrade And A Turnaround Story That Still Looks Undervalued
Simply Wall St. · 20d ago
3 of Wall Street’s Favorite Stocks Worth Investigating
StockStory · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.